They can activate PPAR‐γ, which are expressed in various regions of the brain, regulating a range of activities that positively influence the pathology of Alzheimer's disease, including reducing insulin resistance, inhibiting inflammation, improving mitochondrial function, and reducing tau and amyloid pathology.9, 30, 31. Here, PPARG is linked to early-onset autosomal dominant Alzheimer disease.